![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 12, 2008 12:33:15 PM
link:
http://www.mesotheliomasos.com/treatmentOnconase.php
Onconase (ranpirnase)
Currently in clinical trials, Onconase, manufactured by Alfacell Corporation, offers hope to patients with unresectable malignant mesothelioma. Developed from the eggs of the leopard frog, Onconase is a ribonuclease protein that is designed to enhance the anti-cancer effects of traditional chemotherapy, allowing lower doses to be effective and causing fewer adverse side effects. Though Onconase works slowly, its lower toxicity levels mean no loss of hair, anemia, or nausea usually associated with standard chemo drugs.
Technically speaking, Onconase slows down cancer cell growth by decaying RNA. Without certain RNA strands, cancer cells cannot produce certain essential proteins and, therefore, cannot replicate. This serves to slow the growth of the tumor.
While Phase III trials are currently underway, treating approximately 300 patients that have been stricken with inoperable malignant mesothelioma, the results of Phase II trials, released in 2002, demonstrated that “the tumors either shrank or stopped growing in 41 of the 81 patients that were assessable for tumor response.” The median survival of the patients who entered the trial without symptoms from the cancer was 18.5 months.
Onconase is also one of the first embryonic stem cell products to reach the final stages of testing. Doctors hope to soon be using Onconase in place of Doxorubicin, a chemotherapy drug with crippling side effects that have a serious effect on the patient’s quality of life.
Recent ACEL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 01:55:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 11:38:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 08:28:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 11:05:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/31/2024 09:30:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 12:15:23 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/30/2024 08:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:13:01 PM
- Accel Entertainment Announces Q2 2024 Operating Results • Business Wire • 07/30/2024 08:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 12:06:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 09:46:13 PM
- Accel Entertainment, Inc. to Announce Second Quarter 2024 Financial Results • Business Wire • 07/17/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:05:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 09:01:05 PM
- Accel Entertainment to acquire Fairmount Holdings, owner of FanDuel Sportsbook & Horse Racing in Collinsville, Illinois, broadening Accel’s reach in the local gaming market • Business Wire • 07/15/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 09:21:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/12/2024 08:34:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/12/2024 08:33:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 11:19:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 11:14:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 11:11:04 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM